Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-19T22:13:14.187Z Has data issue: false hasContentIssue false
  • English
  • Français

Influence of mechanical ventilation and inhalation of pulmonary vasodilators, upon pulmonary blood flow and pulmonary vascular resistance

Published online by Cambridge University Press:  19 August 2008

Hartmut Kern  and
Wolfgang J. Kox
Hartmut Kern*
Affiliation:
Department of Anaesthesiology and Intensive Care Medicine, University Hospital Charité (Standort Mitte). Humboldt-University Berlin, Germany
Wolfgang J. Kox
Affiliation:
Department of Anaesthesiology and Intensive Care Medicine, University Hospital Charité (Standort Mitte). Humboldt-University Berlin, Germany
*
Hartmut Kern, MD, Dept of Anesthesiology Intensive Care Medicine, University Hospital Charite (Standort Mitte), Humboldt-University Berlin, Schumannstr 20 21, 10117 Berlin, Germany Tel +49–30–2802 2808, Fax +49–20–2802 5065 E-mail [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Ventilationright heart failurepulmonary hypertensioninhalationvasodilatorsFonran operation
Type
Continuing Medical Education
Information
Cardiology in the Young , Volume 10 , Issue 2 , March 2000 , pp. 166 - 170
Copyright
Copyright © Cambridge University Press 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Rounds, S, Hill, NS: Pulmonary hypertensive diseases. Chest 1984; 85: 397–405CrossRefGoogle ScholarPubMed
2.Gurtner, HP: Chronisch pulmonale Hypertonic vaskulären Ursprungs, plexogene pulnionale Arteriopathie und der AppetitzOgler Aminorex: Nachiese zu einer Epidemic. Schweiz Med Wschr 1982; 115: 782–789Google Scholar
3.Peckham, GJ, Fox, WW. Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hyperrension. J Pediatr 1981; 93: 1005–1010Google Scholar
4.Field, S, Kelly, SM, Macklem, PT: The oxygen cost of breathing in patients with cardiorespiratory disease. Am Rev Resp Dis 1982; 131: 822–827Google Scholar
5.Cassidy, SS, Robertson, CH, Pierce, AK, Johnson, RL. Cardiovascular effects of positive-endexpiratory pressure in dogs. J Appl Physiol 1978; 44: 743–750CrossRefGoogle Scholar
6.DiCarlo, JV, Steven, JM. Respiratory failure in congenital heart disease. Ped Clin North Amer 1994; 41: 525–542CrossRefGoogle ScholarPubMed
7.Suter, PM, Fairley, HB, Isenberg, MD. Optimum end-expiratory airway pressure in patients with acute pulmonary failure. New Engl J Med 1975; 292: 284–289CrossRefGoogle ScholarPubMed
8.Williams, DB, Kiernan, PD, Metke, MP, Marsh, HM, Danielson, GK: Hemodynamic response to positive end-expiratory pressure following right atrium-pulmonary artery bypass (Fontan Procedure). J Thorac Cardiovasc Surg 1984: 87: 856–861Google Scholar
9.McBride, WT, McMurray, TJ. Prolonged high frequency jet ventilation and milrinone therapy following modified Fontan procedure. Anesthesia 1994; 49: 312–314Google Scholar
10.Bailey, JM, Miller, BE, Lu, W, Tosone, SR, Kanter, K, Tam, VKH. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 1999; 90: 1012–1018Google Scholar
11.Higenbotam, T, Wells, F, Wheeldon, D, Wallwork, J. Long-term treatment of pulmonary hypertension with continuous intra venous epoprostenol (prostacyclin). Lancer 1984, 1046–1047CrossRefGoogle Scholar
12.Benzing, A, Mols, G, Geiger, K. Large increase in cardiac output in a patient with ARDS and acute right heart failure during inhalation of nitric oxide. Acta Anaesth Scand 1997; 41: 643–646Google Scholar
13.Journois, D, Pouard, P, Mauriat, P, Malhère, T, Vouhé, P, Safran, D. Inhaled nitric oxide as a therpy for pumonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994; 197: 1129–1135CrossRefGoogle Scholar
14.Miller, OL, Celermajer, DS, Deanfleld, jE, Macrae, DJ. Very-low- dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108: 487–494Google Scholar
15.Olschewski, H, Walmrath, D, Schermuly, R, Ghofrani, A, Grimminger, F, Seeger, W, Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann mt Med 1996; 124 820–824Google ScholarPubMed
16.Shekerdemian, LS, Shore, DF, Lincoln, C, Bush, A, Redington, AN. Negative-pressure ventilation improves cardiac output after right heart surgery. Circulation 1996; 94 [suppl II]: II–49–II–55Google Scholar
17.Shekerdemian, LS, Bush, A, Shore, DF, Lincoln, C, Redington, NA. Cardiopulmonary interactions after Fontan operations: augmentation of cardiac output using negative pressure venti lation. Circulation 1997; 96: 3934–3942Google Scholar
18.Weldner, PW, Myers, JL, Gleason, MM, Cyran, SE, Weber, HS, White, MG, Baylen, BG. The Norwood operation and subse quent Fontan operation in infants with complex congenital heart disease. J Thorac Cardiovasc Surg 1995; 109: 654–662Google Scholar